Page last updated: 2024-08-17

spironolactone and epidermal growth factor

spironolactone has been researched along with epidermal growth factor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dorrance, AM; Grekin, R; Osborn, HL; Webb, RC	1

Other Studies

1 other study(ies) available for spironolactone and epidermal growth factor

Article	Year
Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 281, Issue:3 Topics: Aldosterone; Animals; Aorta; Basal Ganglia; Blood Pressure; Body Weight; Cerebral Cortex; Cerebral Infarction; Epidermal Growth Factor; ErbB Receptors; Genetic Predisposition to Disease; In Vitro Techniques; Infarction, Middle Cerebral Artery; Male; Mineralocorticoid Receptor Antagonists; Ophthalmic Artery; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Spironolactone; Stroke	2001

Article

Year

Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats.

American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 281, Issue:3

Topics: Aldosterone; Animals; Aorta; Basal Ganglia; Blood Pressure; Body Weight; Cerebral Cortex; Cerebral Infarction; Epidermal Growth Factor; ErbB Receptors; Genetic Predisposition to Disease; In Vitro Techniques; Infarction, Middle Cerebral Artery; Male; Mineralocorticoid Receptor Antagonists; Ophthalmic Artery; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Spironolactone; Stroke

2001